Clinical Trials Browser

Waldenstrom Macroglobulinemia × talquetamab × Plasma cell × Clear all

NCT07474961 2026-03-16

BLOOD-dose

Phase 4 Not yet recruiting

LymphoidPlasma cell

Waldenstrom Macroglobulinemia, Multiple Myeloma